Literature DB >> 26409601

The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses.

Clazien Bouwmans1, Marieke Krol2, Hans Severens3, Marc Koopmanschap3, Werner Brouwer4, Leona Hakkaart-van Roijen2.   

Abstract

BACKGROUND: Productivity losses often contribute significantly to the total costs in economic evaluations adopting a societal perspective. Currently, no consensus exists on the measurement and valuation of productivity losses.
OBJECTIVE: We aimed to develop a standardized instrument for measuring and valuing productivity losses.
METHODS: A group of researchers with extensive experience in measuring and valuing productivity losses designed an instrument suitable for self-completion, building on preknowledge and evidence on validity. The instrument was designed to cover all domains of productivity losses, thus allowing quantification and valuation of all productivity losses. A feasibility study was performed to check the questionnaire's consistency and intelligibility.
RESULTS: The iMTA Productivity Cost Questionnaire (iPCQ) includes three modules measuring productivity losses of paid work due to 1) absenteeism and 2) presenteeism and productivity losses related to 3) unpaid work. Questions for measuring absenteeism and presenteeism were derived from existing validated questionnaires. Because validated measures of losses of unpaid work are scarce, the questions of this module were newly developed. To enhance the instrument's feasibility, simple language was used. The feasibility study included 195 respondents (response rate 80%) older than 18 years. Seven percent (n = 13) identified problems while filling in the iPCQ, including problems with the questionnaire's instructions and routing (n = 6) and wording (n = 2). Five respondents experienced difficulties in estimating the time that would be needed for other people to make up for lost unpaid work.
CONCLUSIONS: Most modules of the iPCQ are based on validated questions derived from previously available instruments. The instrument is understandable for most of the general public.
Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  absenteeism; presenteeism; productivity losses; unpaid work

Mesh:

Year:  2015        PMID: 26409601     DOI: 10.1016/j.jval.2015.05.009

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  136 in total

1.  From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare.

Authors:  Matthijs Versteegh; Saskia Knies; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2016-11       Impact factor: 4.981

Review 2.  A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can't Pay the Co-Pay.

Authors:  Louisa G Gordon; Katharina M D Merollini; Anthony Lowe; Raymond J Chan
Journal:  Patient       Date:  2017-06       Impact factor: 3.883

3.  Productivity Loss and Associated Costs Among Patients with Transfusion-Dependent Thalassemia in Dubai, United Arab Emirates.

Authors:  Shaikha Alshamsi; Samer Hamidi; Hacer Ozgen Narci
Journal:  Clinicoecon Outcomes Res       Date:  2021-09-29

4.  Cost-effectiveness of a smartphone Application for Tinnitus Treatment (the CATT trial): a study protocol of a randomised controlled trial.

Authors:  Annick Gilles; Sarah Michiels; Sara Demoen; Laure Jacquemin; Annick Timmermans; Vincent Van Rompaey; Olivier Vanderveken; Hanne Vermeersch; Iris Joossen; Julie Van Eetvelde; Winfried Schlee; Wim Marneffe; Janis Luyten
Journal:  Trials       Date:  2022-05-23       Impact factor: 2.728

5.  Improving mental health and social participation outcomes in older adults with depression and anxiety: Study protocol for a randomised controlled trial.

Authors:  Jessamine Tsan-Hsiang Chen; Viviana M Wuthrich; Ronald M Rapee; Brian Draper; Henry Brodaty; Henry Cutler; Lee-Fay Low; Andrew Georgiou; Carly Johnco; Michael Jones; Denise Meuldijk; Andrew Partington
Journal:  PLoS One       Date:  2022-06-27       Impact factor: 3.752

6.  Test-Retest Reliability, Agreement and Responsiveness of Productivity Loss (iPCQ-VR) and Healthcare Utilization (TiCP-VR) Questionnaires for Sick Workers with Chronic Musculoskeletal Pain.

Authors:  Timo T Beemster; Judith M van Velzen; Coen A M van Bennekom; Michiel F Reneman; Monique H W Frings-Dresen
Journal:  J Occup Rehabil       Date:  2019-03

Review 7.  Financial toxicity associated with treatment of localized prostate cancer.

Authors:  Brandon S Imber; Melissa Varghese; Behfar Ehdaie; Daniel Gorovets
Journal:  Nat Rev Urol       Date:  2019-12-02       Impact factor: 14.432

8.  Measurement Properties of the Work Ability Score in Sick-Listed Workers with Chronic Musculoskeletal Pain.

Authors:  M Stienstra; M J A Edelaar; B Fritz; M F Reneman
Journal:  J Occup Rehabil       Date:  2021-05-26

9.  A referral aid for smoking cessation interventions in primary care: study protocol for a randomized controlled trial.

Authors:  Daniëlle N Zijlstra; Jean W M Muris; Catherine Bolman; J Mathis Elling; Vera E R A Knapen; Hein de Vries
Journal:  Prim Health Care Res Dev       Date:  2021-05-26       Impact factor: 1.458

10.  Cost-effectiveness of single-layer versus double-layer uterine closure during caesarean section on postmenstrual spotting: economic evaluation alongside a randomised controlled trial.

Authors:  Sanne I Stegwee; Ângela J Ben; Mohamed El Alili; Lucet F van der Voet; Christianne J M de Groot; Judith E Bosmans; Judith A F Huirne
Journal:  BMJ Open       Date:  2021-07-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.